Binhui Zhou | Biology and Life Sciences | Best Researcher Award

Binhui Zhou | Biology and Life Sciences | Best Researcher Award

Assoc. Prof. Dr Binhui Zhou, Institute of Psychiatry and Neuroscience, China

Assoc. Prof. Dr. Binhui Zhou is a leading researcher in molecular biology and neuroscience, renowned for his work in protein palmitoylation and its implications in cancer and immune disorders πŸ”¬πŸ§ . He earned his Ph.D. in Crop Genetics and Breeding from Hainan University and currently serves as an Associate Professor at the Institute of Neuropsychiatry and Neuroscience, Xinxiang Medical University πŸŽ“πŸ₯. With over a decade of research, Dr. Zhou has pioneered studies funded by the National Natural Science Foundation of China and the Henan Provincial Foreign Expert Project πŸ‡¨πŸ‡³πŸŒŸ. His groundbreaking publications in top-tier journals have significantly advanced our understanding of cellular signaling in diseases such as hepatocellular carcinoma and atherosclerosis 🧬🩸. A highly respected peer reviewer for prestigious journals, he continues to shape the scientific community through innovation and collaboration πŸ€πŸ“š. Dr. Zhou exemplifies excellence in research and stands as a deserving candidate for the Best Researcher Award πŸ†βœ¨.

Publication Profile

Orcid

Education

Dr. Binhui Zhou’s educational journey reflects his strong commitment to bioscience and innovation πŸ“˜πŸ§ͺ. He began his academic career with a Bachelor’s degree in Bioengineering from Ningbo Institute of Technology, Zhejiang University (2005–2009) πŸŽ“πŸ”. His passion for molecular and developmental biology led him to complete a Master’s degree in Developmental Biology at Hainan University (2010–2013), where he gained key insights into cell and tissue growth processes 🌱🧫. He pursued his Ph.D. at the same university in Crop Genetics and Breeding (2013–2017), where his research laid the foundation for his later studies on genetic regulation and disease pathways 🌾🧬. Throughout his education, Dr. Zhou displayed academic excellence, research depth, and a clear focus on translating fundamental biology into clinical relevance. His multidisciplinary academic background supports his current role as a prominent scientist exploring intersections of genetics, immunology, and neuroscience πŸ”πŸ“–πŸ§ .

Experience

Dr. Zhou began his academic career in 2017 as a Lecturer at the Institute of Neuropsychiatry and Neuroscience, Xinxiang Medical University 🏫🧠. Over seven years, he demonstrated outstanding research and teaching capabilities, contributing significantly to the fields of molecular biology and neuroimmunology πŸ“šπŸ”¬. In 2024, he was promoted to Associate Professor in recognition of his impactful work on palmitoylation mechanisms and their clinical relevance in hepatocellular carcinoma and immune regulation 🧬🩺. His leadership in major research projects, such as NSFC Youth Program and Henan Foreign Expert Project, highlights his ability to lead innovative studies with real-world implications πŸŒπŸ“Š. In parallel, Dr. Zhou has served as a mentor to young scientists, shaping the next generation of researchers πŸ‘¨β€πŸ«πŸŒ±. His dedication to cross-disciplinary collaboration and translational science continues to position him at the forefront of biomedical research.

Awards and Honors

Assoc. Prof. Dr. Binhui Zhou has received national recognition for his exceptional contributions to biomedical science 🧬🌟. As a Principal Investigator, he secured prestigious research grants, including the NSFC Youth Program and the Henan Provincial Foreign Expert Project, reflecting his leadership and innovation in high-impact studies πŸ’‘πŸ§ . His work has been published in top-tier journals such as Cell Molecular Immunology, Theranostics, and Journal of Advanced Research, each with high impact factors and broad influence in global science communities πŸ“ˆπŸŒ. As an expert reviewer for journals like Communications Biology and Cell Communication and Signaling, he has helped uphold the integrity and quality of scientific publishing πŸ“˜πŸ§ͺ. Moreover, Dr. Zhou was appointed as a reviewer for the NSFC Youth Program, a mark of his standing in China’s scientific elite πŸ‡¨πŸ‡³πŸ“œ. These accolades affirm his merit for the Best Researcher Award πŸ…πŸ‘.

Research Focus

Dr. Zhou’s research primarily explores protein palmitoylation, a lipid modification process critical in regulating cellular signaling pathways in diseases such as cancer, atherosclerosis, and immune dysfunctions πŸ§ͺ🧠. He focuses on zDHHC family palmitoyltransferases, particularly zDHHC1, zDHHC2, and zDHHC6, and their roles in modulating protein function in hepatocellular carcinoma and inflammatory responses πŸ”¬πŸ§¬. His investigations have revealed mechanisms by which these enzymes control immune cell behavior and cancer cell proliferation, contributing to therapeutic target discovery πŸ’ŠπŸ”. Notably, his studies on Foxp3 palmitoylation have uncovered novel immune regulatory pathways. Dr. Zhou also examines the PI3K-Akt-mTOR axis in relation to atherosclerosis, offering insights into cardiovascular disease treatment πŸ«€πŸ“Š. His interdisciplinary approach bridges molecular biology, immunology, and neuroscience, pushing the boundaries of biomedical knowledge and guiding new treatment strategies across multiple health conditions 🀝🌍. His research stands at the forefront of cellular signaling and translational medicine πŸš€πŸ§«.

Publication Top Notes

David Nwikwe | Biology and Life Sciences | Best Researcher Award

David Nwikwe | Biology and Life Sciences | Best Researcher Award

Dr David Nwikwe, Kings University, Nigeria, Nigeria

Dr. David Nwikwe πŸŽ“ is a passionate biochemist specializing in toxicology, pharmacology, and antioxidant research. He earned his Ph.D. (2022), M.Sc. (2016), and B.Sc. (2013) in Biochemistry from the University of Ilorin πŸ‡³πŸ‡¬. Currently a Lecturer at Kings University and a Volunteer Instructor at the University of the People 🌍, he has published extensively on hepatotoxicity, antimalarial activity, and oxidative stress. Dr. Nwikwe has received multiple excellence awards for research and peer reviewing πŸ…. His NGO work focuses on health advocacy, disaster management, and youth development, reflecting his commitment to science and community well-being ❀️.

Publication Profile

Google Scholar

Academic Excellence

Dr. David Nwikwe holds a Ph.D. in Biochemistry πŸŽ“, distinguished by the prestigious Outstanding Ph.D. Graduate Award πŸ†. His academic journey reflects unwavering dedication, progressing from a B.Sc. to a Ph.D. at the University of Ilorin πŸ“š. Driven by a passion for scientific excellence πŸ”¬, Dr. Nwikwe has demonstrated exceptional commitment to research and academic growth 🌱. His achievements highlight not only his intellectual prowess but also his perseverance in the dynamic field of biochemistry βš—οΈ. With a strong foundation in scientific inquiry and innovation, he continues to inspire future scholars and contribute significantly to biochemical research 🌍.

Teaching and Mentorship

Dr. David Nwikwe is a dedicated academic, serving as a Lecturer at Kings University and an Instructor at the University of the People πŸŽ“. He actively mentors undergraduates, fostering their academic growth while efficiently managing departmental affairs πŸ“š. Dr. Nwikwe’s leadership shines through his pivotal role in coordinating NUC accreditation processes βœ… and supervising various academic activities. His commitment to excellence and mentorship reflects his passion for shaping future scholars 🌟. Through his dynamic roles, he contributes significantly to academic development, inspiring students and colleagues alike 🌍.

Global Impact and Community Engagement

Dr. David Nwikwe is dedicated to making a societal impact beyond academics πŸŒπŸ“š. His active involvement in NGO projects funded by international bodies like the EU and Global Fund Canada highlights his commitment to global development 🀝🌐. Dr. Nwikwe has contributed to initiatives focused on malaria control 🦟🚫, gender-based issues ⚧️πŸ’ͺ, and adolescent health πŸ‘©β€βš•οΈπŸ§‘β€βš•οΈ, reflecting a holistic approach to research and community well-being. His work bridges the gap between scientific research and real-world challenges, promoting health, equality, and sustainable development 🌱❀️.

Honors and Awards

Dr. David Nwikwe, a distinguished scholar from the Faculty of Life Sciences, University of Ilorin, received the Award for Outstanding PhD Graduate in 2023 πŸ†. His leadership journey began early, serving as Class Monitor at Ade-Oshodi Memorial Baptist Primary School (1994-1999) πŸ“š and later as Senior Prefect and Class Monitor at Okesuna High School, Lagos (1999-2005) πŸŽ“. He won the Best Student Award in the “Spelling Bee” (Zonal Secondary School Category) organized by New Era Foundation in 2005 🐝. David continued his leadership roles as Class Representative during his National Diploma at Kwara State Polytechnic (2007-2009) and M.Sc. Biochemistry program at the University of Ilorin (2014-2016) πŸ§ͺ.

Research Focus

Dr. David Nwikwe’s research focuses on toxicology, pharmacology, and natural product studies πŸ§ͺ🌿. His work explores the hepatotoxic effects of drugs like Synriamβ„’ πŸ₯, the toxicological impact of nanoparticles in water systems πŸ’§βš—οΈ, and the antioxidant and anti-inflammatory properties of plant extracts such as Syzygium aromaticum and Capsicum frutescens 🌱🩺. He also investigates antimalarial activities, oxidative stress reduction, and the modulatory effects of substances like ethanol with Nicotiana tabacum and Cannabis sativa 🧬🧠. His multidisciplinary approach blends in-vivo, in-silico, and molecular docking studies πŸ”¬πŸ’», contributing significantly to biomedical and environmental health sciences 🌍.

Publication Top Notes

Assessment of hepatotoxicity effects of long term administration of SynriamTM in rats

Toxicological assessment of ZnO-Vernonia amygdalina nanoparticle-treated Asa River water in albino rats

ANTIOXIDANT AND ANTI-INFLAMMATORY POTENTIALS OF METHANOL EXTRACT OF SYZYGIUM AROMATICUM L. FLOWER BUDS ON FORMALIN-INDUCED PAW OEDEMA IN RATS

Study on Antimalarial Activity of Capsicum frutescens L. Fruit Extracts during Early and Established Plasmodium Infection in Mice

Evaluation of Cryptolepis sanguinolenta Stem Ethanol Extract in Animal Models

Assessing the Oxidative Stress Reducing Potential ofΒ Spilanthes filicaulisΒ (Schumach & Thonn) Ethyl-Acetate Sub-fractions onΒ Plasmodium bergheiΒ Infected …

Effects of sprouting on the antioxidant potentials of garlic (Allium sativum L.) And onions (Allium cepa L.)

Modulatory Effects of Ethanol with Nicotiana Tabacum and Cannabis Sativa on Markers of Brain Function and Haematological Parameters: In-Vivo and In-Silico Approach

4-Nitrobenzoic Acid and Azaperone from Thaumatococcus daniellii Leaves as Potential Green Preservative Against Fungal Infestation of Cereals with Molecular Docking Studies

Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Prof Hiranmoy Das, Texas Tech University Health Sciences Center, United States

Prof. Hiranmoy Das, MSc, PhD, FAHA, is a renowned biochemist and pharmacologist with a distinguished career. He holds a Ph.D. from the University of Calcutta and has postdoctoral training from prestigious institutions like Harvard Medical School and the Hyogo Institute of Clinical Research. Currently a Professor at Texas Tech University, his research focuses on cardiovascular stem cell therapies, regenerative medicine, and immunology. He has received numerous awards, including induction into the National Academy of Inventors and the American Heart Association. Prof. Das has authored several publications and holds multiple patents. πŸŒŸπŸ“šπŸ’‰πŸ”¬πŸ§¬

Publication Profile

Google Scholar

Education

Prof. Hiranmoy Das holds a Ph.D. in Biochemistry from the University of Calcutta (1995) and has extensive academic training in zoology, advanced cytogenetics, immunology, and biology. He completed postdoctoral fellowships at prestigious institutions, including Harvard Medical School (1999-2002) and Hyogo Institute of Clinical Research, Japan (1996-1999). Prof. Das has held prominent roles, such as Professor at Texas Tech University (2016-present) and Associate Professor at The Ohio State University (2008-2016). He also directed cardiovascular stem cell research laboratories. His remarkable career spans over decades, focusing on innovative research in the fields of biochemistry and immunology. πŸ“šπŸ’‰πŸ”¬

Honors and Awards

Prof. Hiranmoy Das, a distinguished researcher and educator, has received numerous accolades for his groundbreaking contributions. In 2024, he was elected as a Fellow of the National Academy of Inventors. He was inducted into the prestigious Sigma Xi in 2023 and awarded the President’s Excellence in Research Award in 2022. As a tenured professor at Texas Tech University, he earned the Chancellor’s Council Distinguished Research Award in 2021. His honors also include the American Heart Association Fellowship (2021) and a Keynote Speaker role at an International Conference in 2018. Earlier awards include the NIH K01 Award and National Merit Scholarship. πŸ†πŸ”¬πŸŽ“

Experiences

Prof. Hiranmoy Das has taught a variety of undergraduate, graduate, and professional courses at TTUHSC, including leadership roles in Pharmaceutical Sciences Research (G) in Spring, Summer, and Fall sessions from 2021 to 2024 πŸ“š. He led courses like Clinical Correlation-6 and Integrated Therapy and Practice VII, as well as Experimental Design and Biostatistics πŸ§ͺ. Prof. Das has mentored students in clinical and research settings, contributing significantly to pharmaceutical education πŸ’‘. His commitment to fostering academic growth is reflected in his continued leadership in research-focused courses, impacting future professionals in the field of pharmaceutical sciences πŸŽ“.

PhD Thesis

Prof. Hiranmoy Das appears to be heavily involved in mentoring and advising graduate students, particularly in the fields related to pharmacy, veterinary medicine, and health sciences. His research likely focuses on advanced pharmaceutical sciences, drug development, and therapeutics. With his role in advising students pursuing PhD and MS theses, his research could be centered around pharmaceutical applications, medicinal chemistry, or pharmacology. Given his involvement in both veterinary and pharmacy programs, his research may also bridge the gap between human and veterinary health, focusing on biomedical sciences, drug formulations, and therapeutics for both sectors. πŸ“šπŸ’ŠπŸΎπŸ‘©β€πŸ”¬πŸ‘¨β€πŸ”¬

Research Focus

Hiranmoy Das focuses on molecular and cellular biology, particularly related to vascular biology, immunology, and inflammation. His research delves into the roles of Kruppel-like factor 2 (KLF2) in endothelial cells, immune responses, and its regulatory functions in cardiovascular health. He also investigates autophagy, cell death, and ischemic stroke therapies, emphasizing the use of assays for monitoring these processes. His work highlights the role of phytochemicals in cancer prevention and the immune system’s effector functions. Das has made significant contributions to understanding cellular signaling and disease mechanisms, with implications for therapeutic development. πŸ”¬πŸ’‰πŸ§¬πŸ«€

Publication Profile

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

Current advances in ischemic stroke research and therapies

MICA engagement by human VΞ³2VΞ΄2 T cells enhances their antigen-dependent effector function

Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells

Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes

CD1-mediated Ξ³/Ξ΄ T cell maturation of dendritic cells